Lithium tested as potential treatment for rare genetic brain disorder
NCT ID NCT06776848
Summary
This study is testing whether a drug called lithium carbonate can help improve daily living skills and behavior in people with a rare genetic condition called TBR1-related neurocognitive disorder. The trial will involve about 12 participants, aged 6 and older, who have a confirmed TBR1 gene change. After an initial observation period, participants will take lithium for 24 months to see if it is safe and if it helps with their learning and social challenges.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROVEN PATHOGENIC OR PROBABLY PATHOGENIC TBR1 VARIANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Dijon Bourgogne
RECRUITINGDijon, 21000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.